“…However, 16 studies concern the optimization of treatment decisions [32][33][34][35][36][37][38][39][40][41][42][43][44][45][46][47]. Five studies use the MDP to optimize treatment decisions for cancer [30,35,39,42,43], five focus on optimizing the treatment of diabetes mellitus [31][32][33][34]41], and the remaining (N = 13) studies are concerned with liver diseases [27,28], high blood pressure/hypertension [37,40], hepatitis C [44], atherosclerotic cardiovascular disease [45], ischemic heart disease [29,36], atrial fibrillation [38], anemia [47], tuberculosis [46], aneurysms [25], and stroke [26].…”